VBI-1501A

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVBI-1501A
Drug Alias NameVBI-1501A
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEpixisVbi Vaccines Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVbi Vaccines Inc
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A